Obesity, where it is used with other weight reduction measures,such as dietary control, in those with BMI≥30.
120mg immediately after or before meals [max. 360mg daily]. Maximum period of treat- ment is 2 years.
Mode of action
Brands containing this Ingredient
Drug Index 2.0 is hereOur new update features a more powerful search feature and easier login.
issues? Contact us
today. Contact Us
Mode of Action
A pancreatic lipase inhibitor that reduces the absorption of up to 30% dietary fat
Diabetes mellitus; absorption of fat soluble vitamins may be affected; to continue treatment for a period of over one year only after reviewing the risks involved; regaining of weight after stopping treatment.
Pregnancy and breastfeeding; chronic malabsorption syndrome; cholestasis.